CONMED Corp

CNMDReported to SECin USCIK 0000816956Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 7. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 7
Form 4 lines at CONMED Corp, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Kelderman Kim—Option exercisenothing paid500 sharesSep 10, 2026Kelderman Kimnothing paidExercise · Sep 10Option exercise500Sep 10, 2026
Kelderman Kim—Option exercisenothing paid500 sharesSep 10, 2026Kelderman Kimnothing paidExercise · Sep 10Option exercise500Sep 10, 2026
Gallagher John EExecutive Vice President & CFOAwardnothing paid30,536 sharesJul 17, 2026Gallagher John EExecutive Vice President & CFOnothing paidAward · Jul 17Award30,536Jul 17, 2026
Gallagher John EExecutive Vice President & CFOAwardnothing paid26,875 sharesJul 17, 2026Gallagher John EExecutive Vice President & CFOnothing paidAward · Jul 17Award26,875Jul 17, 2026
Gallagher John EExecutive Vice President & CFOAwardnothing paid35,054 sharesJul 17, 2026Gallagher John EExecutive Vice President & CFOnothing paidAward · Jul 17Award35,054Jul 17, 2026